Steven Mintz - Director at Serina Therapeutics, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Steven Mintz since 22 Oct 2025

Reported holdings for Steven Mintz in Serina Therapeutics, Inc.

Form 4 holding Director

Serina Therapeutics, Inc.

Security class
Common Stock
Shares / value
17,443
Estimated value
$112,839
Report date
12 Sep 2024
Price
$6.47
Ownership
By Spouse
Form 4 holding Director

Serina Therapeutics, Inc.

Security class
Common Stock
Shares / value
3,040
Estimated value
$19,666
Report date
12 Sep 2024
Price
$6.47
Ownership
By Adult Child 1
Form 4 holding Director

Serina Therapeutics, Inc.

Security class
Common Stock
Shares / value
2,840
Estimated value
$18,372
Report date
12 Sep 2024
Price
$6.47
Ownership
By Adult Child 2
Form 4 holding Director

Serina Therapeutics, Inc.

Security class
Common Stock
Shares / value
2,650
Estimated value
$17,143
Report date
12 Sep 2024
Price
$6.47
Ownership
By Adult Child 3
Form 4 holding Director

AgeX Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
41,812
Estimated value
Report date
01 Apr 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Steven Mintz in Serina Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .